Robert Whitfield MDAmerica's Breast Implant Illness Expert™

Hip Replacement Rejection: The Invisible Battle Explained #shorts

9 Jun 2026 · 1 min

Watch on YouTube

1:05

In this short video, Dr. Robert Whitfield discusses a challenging case of a young woman in her 30s whose titanium hip replacement repeatedly fails, prompting repeated surgeries. He links the implant rejection to mast cell activation syndrome (MCAS), chronic infections, and environmental factors such as mold exposure. Dr. Whitfield emphasizes the importance of identifying and removing low‑hanging environmental triggers to mitigate mast cell‑driven inflammation. He references a consensus diagnostic paper for MCAS, noting that while some patients meet formal criteria, he also treats those who exhibit clinical signs of MCAS even without a formal diagnosis, thereby expanding therapeutic options.

Chapters

I have a patient who keeps rejecting her hip replacement, the titanium. She's a young woman in her 30s. Oh my gosh. And she's rejected this hip so many times and she needs surgery again. And the surgeon's worried it's not gonna take. So this is part of the problem. We've had, you know, we've seen like mesh move across the body from like a hernia repair, the mast cells are trying to attack. But some patients have chronic infections or they're living in mold, right? It's a constant conversation about eliminating triggers. We always talk about what can we do? What are the low-hanging fruit that we can remove? 'Cause some of these things are bigger, right? So whatever you can do on a daily basis to remove the obvious triggers, right? That's what we work towards. And then we, you know, ideally I'm diagnosing them officially according to our paper that was a consensus to criteria and they have a diagnosis. So now we're gonna, and some of them don't get a diagnosis. I still treat them if they're clinically, you know, looks like they have MCAS, right? Okay, so I'm not going to exclude them, but if they have the diagnosis, maybe I have more options, let's say.